DimAb®Therapeutic Lead Antibody Molecules
DIMA biotech has generated hundreds of the target specific B cell seed libraries and rabbit monoclonal antibodies (mAbs) against various druggable targets. All mAbs are fully sequenced and validated by FACs and ELISA assays. Biopharmaceutical customers can directly analyze the druggability of these pre-developed and validated mAbs molecules to accelerate the progress of their drug discovery. They don’t need to go through the high-risk and time-consuming lead molecules discovery stage internally or count on CRO companies for the screening of lead molecules.
Learn More